How gut microbiota relate to the oral antidiabetic treatment of type 2 diabetes
The theory of ominous octet proposed by Dr. Defronzo in 2008 has emphasized the underlying complicated pathogenesis mechanism in type 2 diabetes. Recently it was further identified that gut microbiota dysbiosis is also closely related to development of chronic inflammations related diseases includin...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-03-01
|
Series: | Medicine in Microecology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590097820300045 |
id |
doaj-031b6c610d23438f93b53de8f7697155 |
---|---|
record_format |
Article |
spelling |
doaj-031b6c610d23438f93b53de8f76971552021-02-05T15:32:25ZengElsevierMedicine in Microecology2590-09782020-03-013100007How gut microbiota relate to the oral antidiabetic treatment of type 2 diabetesWei-Wen Hung0Wei-Chun Hung1Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanDepartment of Microbiology and Immunology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Corresponding author. Department of Microbiology and Immunology, College of Medicine, Kaohsiung Medical University, 100 Shiquan 1st Road, Kaohsiung, 807, Taiwan.The theory of ominous octet proposed by Dr. Defronzo in 2008 has emphasized the underlying complicated pathogenesis mechanism in type 2 diabetes. Recently it was further identified that gut microbiota dysbiosis is also closely related to development of chronic inflammations related diseases including diabetes. Diabetes is characterized by ''leaky gut'' syndrome where bacterial cell wall components enter the blood circulation of animal host in a higher amount. These may cause metabolic endotoxemia and systemic low-grade inflammation, affecting vital organs related to the ominous octet. On the other hand, the bacterial metabolites also systemically affect glucose homeostasis and energy utilization. The effects of current clinically available oral antidiabetic drugs (OAD) are related to altering the compositions of gut microbiota, among which metformin are the most extensively explored. Gut microbiota therefore play an important role as a functional cross-bridge between host environment and the ominous octet, modulating diabetes. With continuing explorations, in the future gut microbiota may serve as a diagnostic biomarker in personalized medicine. Its modulation may also be used as a novel approach to treat type 2 diabetes.http://www.sciencedirect.com/science/article/pii/S2590097820300045 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Wei-Wen Hung Wei-Chun Hung |
spellingShingle |
Wei-Wen Hung Wei-Chun Hung How gut microbiota relate to the oral antidiabetic treatment of type 2 diabetes Medicine in Microecology |
author_facet |
Wei-Wen Hung Wei-Chun Hung |
author_sort |
Wei-Wen Hung |
title |
How gut microbiota relate to the oral antidiabetic treatment of type 2 diabetes |
title_short |
How gut microbiota relate to the oral antidiabetic treatment of type 2 diabetes |
title_full |
How gut microbiota relate to the oral antidiabetic treatment of type 2 diabetes |
title_fullStr |
How gut microbiota relate to the oral antidiabetic treatment of type 2 diabetes |
title_full_unstemmed |
How gut microbiota relate to the oral antidiabetic treatment of type 2 diabetes |
title_sort |
how gut microbiota relate to the oral antidiabetic treatment of type 2 diabetes |
publisher |
Elsevier |
series |
Medicine in Microecology |
issn |
2590-0978 |
publishDate |
2020-03-01 |
description |
The theory of ominous octet proposed by Dr. Defronzo in 2008 has emphasized the underlying complicated pathogenesis mechanism in type 2 diabetes. Recently it was further identified that gut microbiota dysbiosis is also closely related to development of chronic inflammations related diseases including diabetes. Diabetes is characterized by ''leaky gut'' syndrome where bacterial cell wall components enter the blood circulation of animal host in a higher amount. These may cause metabolic endotoxemia and systemic low-grade inflammation, affecting vital organs related to the ominous octet. On the other hand, the bacterial metabolites also systemically affect glucose homeostasis and energy utilization. The effects of current clinically available oral antidiabetic drugs (OAD) are related to altering the compositions of gut microbiota, among which metformin are the most extensively explored. Gut microbiota therefore play an important role as a functional cross-bridge between host environment and the ominous octet, modulating diabetes. With continuing explorations, in the future gut microbiota may serve as a diagnostic biomarker in personalized medicine. Its modulation may also be used as a novel approach to treat type 2 diabetes. |
url |
http://www.sciencedirect.com/science/article/pii/S2590097820300045 |
work_keys_str_mv |
AT weiwenhung howgutmicrobiotarelatetotheoralantidiabetictreatmentoftype2diabetes AT weichunhung howgutmicrobiotarelatetotheoralantidiabetictreatmentoftype2diabetes |
_version_ |
1724283429991743488 |